Toronto - Delayed Quote CAD

Tilray Brands, Inc. (TLRY.TO)

1.7500

-0.2400

(-12.06%)

At close: January 10 at 4:00:00 PM EST

Tilray posts Q2 revenue miss, CEO talks beer market growth

Tilray Brands (TLRY) reported fiscal second quarter earnings, with revenue of $211 million falling short of the estimated $217 million. However, adjusted EPS came in at $0.00, beating expectations of a $0.03 loss. Tilray Brands chairman and CEO Irwin Simon joins Market Domination to discuss these results. Simon highlights the company's expansion into the beer market since late 2020, acquiring 12 brands. He also outlines plans to trim the company's beverage portfolio and introduce 100-145 new products. "This is the right thing for the business," Simon tells Yahoo Finance. He acknowledges the recent pressures and challenges reflected in both earnings and stock performance. "Part of the problem is I'm still looked upon as a Canadian cannabis company," Simon explains. Despite challenges, Simon is optimistic about Tilray and emphasizes the company's successful pivot from cannabis to beer markets. "Everybody does something wrong, but we're doing a lot of great things," he says. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 2 hours ago

TLRY
Tilray Brands (TLRY) Q2 2025 Earnings Call Transcript

TLRY earnings call for the period ending December 31, 2024.

Motley Fool 5 hours ago

TLRY
Why Tilray (TLRY) Shares Are Plunging Today

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 13.5% in the morning session after the company reported underwhelming fourth quarter results. Its revenue and EBITDA missed significantly, and its gross margin fell short of Wall Street's estimates. Also, the company recorded significant operating losses and continued to burn cash. On the other hand, revenue guidance for 2025 came in ahead of expectations, though sales are partly benefiting from recent acquisitions following the company

StockStory 5 hours ago

TLRY
Tilray Reports Q2 Revenue Growth, but Stock Drops Over 11% on Continued Losses

Tilray maintained its fiscal 2025 revenue guidance of $950 million to $1 billion.

GuruFocus.com 8 hours ago

TLRY
Why Tilray Brands Stock Crashed 12% on Friday

Tilray Brands (NASDAQ: TLRY) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report. Heading into the news, Wall Street analysts anticipated Tilray would report sales of $216.3 million for its fiscal second quarter of 2025, ended Nov. 30, but Tilray actually collected just $211 million. On the plus side, Tilray beat expectations for earnings.

Motley Fool 8 hours ago

TLRY
Tilray Brands (TLRY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended November 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 10 hours ago

TLRY
Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates

Tilray Brands (TLRY) delivered earnings and revenue surprises of -150% and 3.33%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 11 hours ago

TLRY

CHD
Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q4 Earnings

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year on year to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.2% above analysts’ estimates. Its non-GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.

StockStory 12 hours ago

TLRY
Tilray Brands Reports Q2 2025 Financial Results

Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK an

GlobeNewswire 12 hours ago

TLRY
Tilray (TLRY) Q4 Earnings: What To Expect

Cannabis company Tilray Brands (NASDAQ:TLRY) will be reporting results tomorrow morning. Here’s what to expect.

StockStory yesterday

TLRY
Fed commentary, Delta earnings, jobs report: What to Watch

Market Domination Overtime anchors Julie Hyman and Josh Lipton highlight key events for the remainder of the week. Stock market trading (^DJI, ^IXIC, ^GSPC) will be closed Thursday for the national day of mourning honoring the late President Jimmy Carter, though bond (^TNX, ^TYX, ^FVX) markets remain open. However, Federal Reserve officials are scheduled to speak, with insights expected on the 2025 rate cut trajectory from Philadelphia Fed president Patrick Harker, Boston Fed president Susan Collins, and Richmond Fed president Tom Barkin. December's jobs report will be released Friday, with economists expecting non-farm payrolls to rise by 165,000 new jobs, while the unemployment rate is projected to hold at 4.2%. Investors will also receive quarterly earnings results from Delta Air Lines (DAL), Tilray Brands (TLRY), and Constellation Brands (STZ). To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith

Yahoo Finance Video 2 days ago

TLRY

STZ

DAL
New York cannabis sales set for $1.5B surge in 2025

New York’s cannabis market is poised for major growth in 2025, with sales expected to hit $1.5 billion and the number of legal marijuana shops more than doubling. Dan Ahrens, AdvisorShares Pure US Cannabis ETF portfolio manager, joins Market Domination to discuss how current political delays and market volatility have affected cannabis stock. "We keep expecting federal reform, we keep getting promised federal reform, and when we had this past election, these cannabis stocks took yet another hit because the investing public out there really thinks that the Republican Party is bad for cannabis," Ahrens explains. He notes the Democratic Party could have been good for cannabis but that "people in our space feel like we've just been gaslighted for the past four years by Democrats.” Ahrens still suggests 2025 could bring change, with cannabis potentially rescheduled as a Schedule III controlled substance, which would be a big positive for companies. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Josh Lynch

Yahoo Finance Video 2 days ago

TLRY

CGC

MJ
Is Tilray Brands, Inc. (TLRY) the Best CBD Stock to Invest In Right Now?

We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against other best CBD stocks to invest in right now. An essential component of medical marijuana, CBD is the legal, non-psychoactive compound that […]

Insider Monkey 2 days ago

TLRY
SweetWater Brewing Launches Daytrip IPA: A New Tropical Escape in Every Sip

Embark on a Sun-Drenched Journey of Flavor with SweetWater Brewing’s Exhilarating New Everyday IPAATLANTA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly unveils its newest craft brew: Daytrip India Pale Ale, a vibrant addition to its year-round flagship line. This easy-drinking brew delivers a refreshing wave of tropical fr

GlobeNewswire 2 days ago

TLRY
Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg highlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis

GlobeNewswire 4 days ago

TLRY
Is Tilray Brands (TLRY) Among the Best Long-Term Penny Stocks to Buy According to Hedge Funds?

We recently published a list of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the other best long-term penny stocks to buy. What’s the Future Like for Small Cap Stocks in 2025? On […]

Insider Monkey 6 days ago

TLRY
Delta earnings, jobs report, Fed minutes: What to Watch

Market Domination Overtime co-hosts Josh Lipton and Josh Schafer highlight next week's top market events. A slew of major corporations are set to report quarterly earnings. Investors can expect reports from Cal-Maine (CALM), Albertsons (ACI), Constellation Brands (STZ), KB Home (KBH), Tilray (TLRY), and Delta Airlines (AAL). On the economic calendar, Friday's December jobs report takes center stage, with economists forecasting nonfarm payrolls to slow to 153,000 and unemployment to stay at 4.2%. The week also features key Federal Reserve events, including speeches from Fed governor Lisa Cook, Fed governor Christopher Waller, Richmond Fed president Tom Barkin, and Philadelphia Fed president Patrick Harker. Additionally, on Wednesday, the December FOMC meeting minutes will be released, providing deeper insight into the central bank's latest interest rate decision. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith

Yahoo Finance Video 7 days ago

KBH

STZ

CALM
Tilray Brands, Inc. (TLRY) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.45, denoting a -0.68% change from the preceding trading day.

Zacks 7 days ago

TLRY
Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

Due to the closure of the Securities and Exchange Commission and U.S. stock markets on January 9, in honor of the late former President Jimmy Carter, Tilray has moved its earnings announcement to January 10NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second

GlobeNewswire 8 days ago

TLRY
Is Tilray Brands (TLRY) the Best Brewery Stock to Buy According to Hedge Funds?

We recently published a list of 12 Best Brewery Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against other best brewery stocks to buy according to hedge funds. The global alcohol industry is currently grappling with strict regulations, high […]

Insider Monkey 10 days ago

TLRY

Performance Overview

Return	TLRY.TO	S&P 500
YTD	-10.71%	-1.35%
1-Year	-38.16%	+22.51%
3-Year	-78.47%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Tilray Brands, Inc. (TLRY.TO)

Tilray posts Q2 revenue miss, CEO talks beer market growth

Tilray Brands (TLRY) Q2 2025 Earnings Call Transcript

Why Tilray (TLRY) Shares Are Plunging Today

Tilray Reports Q2 Revenue Growth, but Stock Drops Over 11% on Continued Losses

Why Tilray Brands Stock Crashed 12% on Friday

Tilray Brands (TLRY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates

Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q4 Earnings

Tilray Brands Reports Q2 2025 Financial Results

Tilray (TLRY) Q4 Earnings: What To Expect

Fed commentary, Delta earnings, jobs report: What to Watch

New York cannabis sales set for $1.5B surge in 2025

Is Tilray Brands, Inc. (TLRY) the Best CBD Stock to Invest In Right Now?

SweetWater Brewing Launches Daytrip IPA: A New Tropical Escape in Every Sip

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Is Tilray Brands (TLRY) Among the Best Long-Term Penny Stocks to Buy According to Hedge Funds?

Delta earnings, jobs report, Fed minutes: What to Watch

Tilray Brands, Inc. (TLRY) Stock Sinks As Market Gains: Here's Why

Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning

Is Tilray Brands (TLRY) the Best Brewery Stock to Buy According to Hedge Funds?

Performance Overview